Why a SpaceX IPO Could Unlock Further Upside in Rocket Lab

Hook & thesis

Rocket Lab (RKLB) is trading like a growth winner: a fresh 52-week high at roughly $150, a $2.2 billion recorded backlog, and a stretch of positive commercial and defense headlines in late May. But the bigger narrative now is external - the highly anticipated SpaceX IPO. If SpaceX lists at the scale markets anticipate, the entire space sector is likely to get re-priced higher. That dynamic creates an asymmetrical opportunity for Rocket Lab: established launch capability, expanding medium-lift ambitions, and a growing space systems business could see multiple expansion simply as investor attention and multiples migrate up the cap table.

My trade idea is a directional long that leans on that rerating thesis while respecting the expensive base the market has already priced in. Entry, stop and target below reflect a mid-term horizon that expects the SpaceX listing process, NASA publicity around lunar programs, and Rocket Lab's own defense wins to catalyze follow-through.

What Rocket Lab does and why the market should care

Rocket Lab operates two business lines: Launch Services and Space Systems. Launch Services sells dedicated and rideshare launches; Space Systems does spacecraft engineering, components, manufacturing and on-orbit operations. The company has been building scale in both areas and is branching into higher-margin, vertically integrated capabilities - recent evidence being the acquisition of Motiv Space Systems and the completion of the Motiv deal that rebranded it as Rocket Lab Robotics (announced 05/26/2026).

Why that matters: launch is a growth market with secular tailwinds - lower launch costs, expanded satellite constellations, and rising government spending on space infrastructure. Rocket Lab is the second-largest US launch provider by some metrics and has been awarded material government work: the company recently cited more than $1.3 billion in defense contracts and successfully passed the System Requirements Review for the Space Development Agency Tracking Layer Tranche 3 (reported 05/27/2026). Those contracts anchor revenue and give the company defense-led upside separate from commercial demand.

Facts and figures that matter

Valuation framing

On headline multiples Rocket Lab is priced like a near-ubiquitous growth winner: price-to-sales ~122x and EV-to-sales ~120x. Those multiples outstrip practically every traditional aerospace peer and align more with hyper-growth software-like expectations. The company has strong revenue growth (Q1 2026 revenue of $200.3M, +63.5% YoY) and a meaningful backlog ($2.2B) supporting near-term revenue visibility, but negative free cash flow (-$316.3M) and negative EPS remain realities.

So why would the market pay up further? The answer is twofold: first, a SpaceX IPO will likely alter the investor lens for the sector by creating a headline comp and a higher-priced benchmark for space assets, particularly Starlink-like businesses. Second, Rocket Lab's defense wins and robotics capabilities (Motiv acquisition completed 05/26/2026) add a higher-margin services and national-security pathway that can support a premium multiple if investors decide to value integrated space systems and not just raw launch volumes.

Catalysts - what could move the stock higher

• SpaceX IPO process and pricing signals - if SpaceX lists at a valuation that validates robust multiples for space companies, sector multiples should expand and lift RKLB.
• Continued defense contract awards and SDA program milestones - the recent System Requirements Review (05/27/2026) and >$1.3B in defense contracts reduce revenue downside risk and increase contractor credibility.
• Integration wins from Motiv acquisition (completed 05/26/2026) and new robotics or lunar/infrastructure contracts.
• Positive quarterly updates showing cadence of launches, margin improvement in Space Systems, or any path to cash flow breakeven.

Trade plan (actionable)

Thesis: SpaceX IPO creates a sector rerating that expands multiples for credible launch and space-systems operators, and Rocket Lab is positioned to capture that rerating given backlog, defense wins and expanded product capability.

Direction: Long

Entry price: $150.23

Stop loss: $125.00

Target price: $210.00

Horizon: mid term (45 trading days) - I expect the bulk of the rerating reaction to occur around SpaceX listing activity, NASA and defense announcements in the coming weeks, and investor repositioning. If the trade proves constructive early, consider trimming into strength. If SpaceX pricing significantly exceeds expectations, I would let a portion run toward higher targets with a trailing stop.

Rationale for levels: entry equals the current market price; the stop protects against a rapid multiple contraction that would wipe out the rerating thesis (a drop below $125 would suggest either execution issues or a sector pullback). The $210 target assumes a material multiple expansion driven by sector reappraisal and positive contract flow; it is ambitious but achievable if SpaceX's listing changes investor willingness to pay for space economy growth.

Risks & counterarguments

• Valuation compression risk: RKLB already trades at elevated multiples (P/S ~122x, EV/S ~120x). Any disappointment on execution, backlog conversion, or slower-than-expected margin expansion could trigger steep downside. A pullback to rationalize multiples is a real risk.
• Execution and cash flow risk: Free cash flow is negative (-$316.3M). If launches face delays, defects, or cost overruns, cash burn will prolong and valuation support may vanish.
• Competition and economics: SpaceX's reusable launch cost advantage and Starlink valuation narrative might actually overshadow smaller launch providers. If investors see SpaceX as the dominant winner, money could concentrate there instead of flowing into second-tier names.
• Technical & crowding risk: Technical indicators are stretched (RSI ~73.6). Short interest has been meaningful at various points and intraday flows can accelerate reversals. A quick sector rotation could flush the name before fundamentals catch up.
• Counterargument: The SpaceX IPO could hurt, not help, Rocket Lab. If SpaceX's valuation is driven overwhelmingly by Starlink-like broadband economics, the market might put a premium only on companies with analogous recurring-revenue satellite broadband models. That could leave launch and spacecraft manufacturers relatively less attractive, meaning the SpaceX IPO could attract capital away from RKLB rather than lift it.

What would change my mind

I will change my bullish stance if Rocket Lab stops converting backlog into revenue on the expected schedule, if reported cash burn materially worsens or if upcoming NASA/SpaceX/Defense milestones are missed. Concretely, a sustained close below $125 with rising volume or evidence that backlog cancellations are material would force me to close the position. Conversely, if the company shows clear FCF improvement and guidance that points toward cash flow breakeven, I would expand conviction and risk-weighted size.

Bottom line

Rocket Lab sits at the intersection of two powerful dynamics: a near-term operational run-rate backed by a $2.2B backlog and a macro-sector narrative that could lift multiples if SpaceX's IPO validates the space economy story. The trade here is a mid-term, catalyst-driven long that bets the next leg of multiple expansion is sector-wide and not exclusive to SpaceX. It is a high-risk, high-reward idea: use disciplined sizing and a strict stop at $125 to limit downside while giving the thesis room to play out around the expected public-market interest in space names.

Key dates to watch: SpaceX IPO developments and pricing windows, NASA moonbase-related announcements, Rocket Lab contract updates and quarterly cadence through the next 45 trading days.